FATE Sale Disclosure
Adawi Kamal · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$13.52K
Adawi Kamal Chief Financial Officer
FATE
Fate Therapeutics
FATE
Transaction date
Nov 3, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 1 day later
FATE daily price context
Close on/before transaction
$2.04
Nov 3, 2026
First close after public filing
$1.85
Nov 5, 2026
Return after filing · so far
-0.81%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,582 shares @ $2.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-447171
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$13.52K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Fate Therapeutics Inc FATE Current | Sale | Nov 3, 2026 | $13.52K |